The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Orosoothe 0.15% w/v Oromucosal Spray

Phoenix LabsPA1113/016/001

Main Information

Trade NameOrosoothe 0.15% w/v Oromucosal Spray
Dosage FormOromucosal spray
Licence HolderPhoenix Labs
Licence NumberPA1113/016/001

Group Information

ATC CodeA01AD02 benzydamine


License statusAuthorised
Licence Issued22/03/2019
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back